Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.
2.

Effect of cryoprotectant composition on in vitro viability of in vitro fertilized and cloned bovine embryos following vitrification and in-straw dilution.

Taniguchi M, Ikeda A, Arikawa E, Wongsrikeao P, Agung B, Naoi H, Nagai T, Otoi T.

J Reprod Dev. 2007 Aug;53(4):963-9. Epub 2007 Apr 10.

3.

Effects of insulin replacements, inhibitors of angiotensin, and PKCbeta's actions to normalize cardiac gene expression and fuel metabolism in diabetic rats.

Arikawa E, Ma RC, Isshiki K, Luptak I, He Z, Yasuda Y, Maeno Y, Patti ME, Weir GC, Harris RA, Zammit VA, Tian R, King GL.

Diabetes. 2007 May;56(5):1410-20. Epub 2007 Mar 15.

4.

Effects of endothelin receptor blockade on hypervasoreactivity in streptozotocin-diabetic rats: vessel-specific involvement of thromboxane A2.

Arikawa E, Cheung C, Sekirov I, Battell ML, Yuen VG, McNeill JH.

Can J Physiol Pharmacol. 2006 Aug-Sep;84(8-9):823-33.

PMID:
17111027
5.

Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice.

Ohshiro Y, Ma RC, Yasuda Y, Hiraoka-Yamamoto J, Clermont AC, Isshiki K, Yagi K, Arikawa E, Kern TS, King GL.

Diabetes. 2006 Nov;55(11):3112-20.

6.

Ovarian follicular and corpus luteum changes, progesterone concentrations, estrus and ovulation following estradiol benzoate/progesterone based treatment protocol in cross-bred cows.

Taniguchi M, Ikeda A, Arikawa E, Shimizu R, Seki M, Karaki M, Rajamahendran R, Otoi T.

Anim Reprod Sci. 2007 Jun;99(3-4):389-94. Epub 2006 Aug 14.

PMID:
16989965
7.

Chronic estrogen treatment modifies insulin-induced insulin resistance and hypertension in ovariectomized rats.

Song D, Arikawa E, Galipeau DM, Yeh JN, Battell ML, Yuen VG, McNeill JH.

Am J Hypertens. 2005 Sep;18(9 Pt 1):1189-94.

PMID:
16182108
8.

Differential regulation of angiotensin II-induced expression of connective tissue growth factor by protein kinase C isoforms in the myocardium.

He Z, Way KJ, Arikawa E, Chou E, Opland DM, Clermont A, Isshiki K, Ma RC, Scott JA, Schoen FJ, Feener EP, King GL.

J Biol Chem. 2005 Apr 22;280(16):15719-26. Epub 2005 Feb 7.

9.

Androgens are necessary for the development of fructose-induced hypertension.

Song D, Arikawa E, Galipeau D, Battell M, McNeill JH.

Hypertension. 2004 Mar;43(3):667-72. Epub 2004 Feb 2.

10.

Exaggerated coronary reactivity to endothelin-1 in diabetes: reversal with bosentan.

Verma S, Arikawa E, Lee S, Dumont AS, Yao L, McNeill JH.

Can J Physiol Pharmacol. 2002 Oct;80(10):980-6.

PMID:
12450064
11.

Chronic thromboxane synthase inhibition prevents fructose-induced hypertension.

Galipeau D, Arikawa E, Sekirov I, McNeill JH.

Hypertension. 2001 Oct;38(4):872-6.

12.

Long-term endothelin receptor blockade improves cardiovascular function in diabetes.

Verma S, Arikawa E, McNeill JH.

Am J Hypertens. 2001 Jul;14(7 Pt 1):679-87.

PMID:
11465653
13.

Chronic bosentan treatment improves renal artery vascular function in diabetes.

Arikawa E, Verma S, Dumont AS, McNeill JH.

J Hypertens. 2001 Apr;19(4):803-12.

PMID:
11330884
14.

Insulin-induced vasodilation is dependent on tetrahydrobiopterin synthesis.

Verma S, Arikawa E, Yao L, Laher I, McNeill JH.

Metabolism. 1998 Sep;47(9):1037-9.

PMID:
9751228
15.

Direct vasodepressor effects of pioglitazone in spontaneously hypertensive rats.

Verma S, Bhanot S, Arikawa E, Yao L, McNeill JH.

Pharmacology. 1998 Jan;56(1):7-16.

PMID:
9467183
16.

Limb-girdle muscular dystrophy: clinical and pathologic reevaluation.

Yamanouchi Y, Arikawa E, Arahata K, Ozawa E, Nonaka I.

J Neurol Sci. 1995 Mar;129(1):15-20.

PMID:
7751838
17.

Nonvacuolar myopathy in a large family with both late adult onset distal myopathy and severe proximal muscular dystrophy.

Udd B, Rapola J, Nokelainen P, Arikawa E, Somer H.

J Neurol Sci. 1992 Dec;113(2):214-21.

PMID:
1487757
18.

Possible influences on the expression of X chromosome-linked dystrophin abnormalities by heterozygosity for autosomal recessive Fukuyama congenital muscular dystrophy.

Beggs AH, Neumann PE, Arahata K, Arikawa E, Nonaka I, Anderson MS, Kunkel LM.

Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):623-7.

19.

The frequency of patients with dystrophin abnormalities in a limb-girdle patient population.

Arikawa E, Hoffman EP, Kaido M, Nonaka I, Sugita H, Arahata K.

Neurology. 1991 Sep;41(9):1491-6.

PMID:
1842672
20.

Immunocytochemical analysis of dystrophin in congenital muscular dystrophy.

Arikawa E, Ishihara T, Nonaka I, Sugita H, Arahata K.

J Neurol Sci. 1991 Sep;105(1):79-87.

PMID:
1795174

Supplemental Content

Loading ...
Support Center